NL154600B
(nl)
|
1971-02-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
NL154599B
(nl)
|
1970-12-28 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
|
US3901654A
(en)
|
1971-06-21 |
1975-08-26 |
Biological Developments |
Receptor assays of biologically active compounds employing biologically specific receptors
|
US3853987A
(en)
|
1971-09-01 |
1974-12-10 |
W Dreyer |
Immunological reagent and radioimmuno assay
|
US3867517A
(en)
|
1971-12-21 |
1975-02-18 |
Abbott Lab |
Direct radioimmunoassay for antigens and their antibodies
|
NL171930C
(nl)
|
1972-05-11 |
1983-06-01 |
Akzo Nv |
Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
|
US3850578A
(en)
|
1973-03-12 |
1974-11-26 |
H Mcconnell |
Process for assaying for biologically active molecules
|
US3935074A
(en)
|
1973-12-17 |
1976-01-27 |
Syva Company |
Antibody steric hindrance immunoassay with two antibodies
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
US4034074A
(en)
|
1974-09-19 |
1977-07-05 |
The Board Of Trustees Of Leland Stanford Junior University |
Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
|
US3984533A
(en)
|
1975-11-13 |
1976-10-05 |
General Electric Company |
Electrophoretic method of detecting antigen-antibody reaction
|
US4098876A
(en)
|
1976-10-26 |
1978-07-04 |
Corning Glass Works |
Reverse sandwich immunoassay
|
US4879219A
(en)
|
1980-09-19 |
1989-11-07 |
General Hospital Corporation |
Immunoassay utilizing monoclonal high affinity IgM antibodies
|
JPS5781447A
(en)
|
1980-11-11 |
1982-05-21 |
Toyo Jozo Co Ltd |
Human chorionic gonadotropic hormone c-terminal fragment
|
US4853332A
(en)
|
1982-10-19 |
1989-08-01 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
|
US5011771A
(en)
|
1984-04-12 |
1991-04-30 |
The General Hospital Corporation |
Multiepitopic immunometric assay
|
DE3421468A1
(de)
|
1984-06-08 |
1985-12-19 |
Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim |
Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
EP0173552B1
(en)
|
1984-08-24 |
1991-10-09 |
The Upjohn Company |
Recombinant dna compounds and the expression of polypeptides such as tpa
|
US4911691A
(en)
|
1984-09-21 |
1990-03-27 |
Menlo Care, Inc. |
Assembly for adminstering IV solution
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
DE122007000007I1
(de)
|
1986-04-09 |
2007-05-16 |
Genzyme Corp |
Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
ATE110571T1
(de)
|
1988-05-06 |
1994-09-15 |
Toray Industries |
Stabile interferon-beta-zusammensetzung.
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
US5338835A
(en)
|
1989-02-21 |
1994-08-16 |
Washington University |
CTP-extended form of FSH
|
US5792460A
(en)
|
1989-02-21 |
1998-08-11 |
Washington University |
Modified glycoprotein hormones having a CTP at the amino terminus
|
WO1990009800A1
(en)
|
1989-02-21 |
1990-09-07 |
Washington University |
Modified forms of reproductive hormones
|
US5705478A
(en)
|
1989-02-21 |
1998-01-06 |
Washington University |
Covalently linked β subunits of the glycoprotein hormones as antagonists
|
US6225449B1
(en)
|
1991-10-04 |
2001-05-01 |
Washington University |
Hormone analogs with multiple CTP extensions
|
US5464764A
(en)
|
1989-08-22 |
1995-11-07 |
University Of Utah Research Foundation |
Positive-negative selection methods and vectors
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
US5126324A
(en)
|
1990-06-07 |
1992-06-30 |
Genentech, Inc. |
Method of enhancing growth in patients using combination therapy
|
US6028177A
(en)
|
1991-10-04 |
2000-02-22 |
Washington University |
Methods of detecting single-chain forms of the glycoprotein hormone quartet
|
US5281521A
(en)
|
1992-07-20 |
1994-01-25 |
The Trustees Of The University Of Pennsylvania |
Modified avidin-biotin technique
|
JP4156024B2
(ja)
|
1993-04-20 |
2008-09-24 |
ワシントン ユニバーシティー |
修飾されたタンパク質及びペプチド医薬品
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US5605976A
(en)
|
1995-05-15 |
1997-02-25 |
Enzon, Inc. |
Method of preparing polyalkylene oxide carboxylic acids
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US6737515B2
(en)
|
1993-11-19 |
2004-05-18 |
Washington University |
Follicle stimulating hormone-glycosylation analogs
|
US6238890B1
(en)
|
1994-02-18 |
2001-05-29 |
Washington University |
Single chain forms of the glycoprotein hormone quartet
|
US5824642A
(en)
|
1994-04-07 |
1998-10-20 |
Genentech, Inc. |
Treatment of partial growth hormone insensitivity syndrome
|
US5935924A
(en)
|
1994-04-15 |
1999-08-10 |
Genentech, Inc. |
Treatment of congestive heart failure
|
US5541110A
(en)
|
1994-05-17 |
1996-07-30 |
Bristol-Myers Squibb |
Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
|
BR9506313A
(pt)
|
1994-08-12 |
1997-08-05 |
Univ Washington |
Formas de cadeia simples do quarteto de hormônio de glicoproteína
|
DE19539493A1
(de)
|
1995-10-24 |
1997-04-30 |
Thomae Gmbh Dr K |
Starker homologer Promotor aus Hamster
|
US6083725A
(en)
|
1996-09-13 |
2000-07-04 |
Transkaryotic Therapies, Inc. |
Tranfected human cells expressing human α-galactosidase A protein
|
US20050032211A1
(en)
|
1996-09-26 |
2005-02-10 |
Metabogal Ltd. |
Cell/tissue culturing device, system and method
|
TW518235B
(en)
|
1997-01-15 |
2003-01-21 |
Akzo Nobel Nv |
A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
|
US6310183B1
(en)
|
1997-09-10 |
2001-10-30 |
Novo Nordisk A/S |
Coagulation factor VIIa composition
|
US6103501A
(en)
|
1997-11-17 |
2000-08-15 |
Washington University |
Single chain glycoprotein hormones comprising two β and one α subunits and recombinant production thereof
|
CN100480266C
(zh)
|
1998-10-16 |
2009-04-22 |
拜奥根Idec马萨诸塞公司 |
干扰素-β融合蛋白及用途
|
US6514729B1
(en)
|
1999-05-12 |
2003-02-04 |
Xencor, Inc. |
Recombinant interferon-beta muteins
|
CA2716369C
(en)
|
1999-05-24 |
2013-05-14 |
Mitsubishi Tanabe Pharma Corporation |
Phenoxypropylamine compounds
|
PE20010288A1
(es)
|
1999-07-02 |
2001-03-07 |
Hoffmann La Roche |
Derivados de eritropoyetina
|
US20010028895A1
(en)
|
2000-02-04 |
2001-10-11 |
Bisgaier Charles L. |
Methods of treating alzheimer's disease
|
US20020127652A1
(en)
|
2000-02-11 |
2002-09-12 |
Schambye Hans Thalsgard |
Follicle stimulating hormones
|
US7094566B2
(en)
|
2000-03-16 |
2006-08-22 |
Amgen Inc., |
IL-17 receptor like molecules and uses thereof
|
US20030036181A1
(en)
|
2000-06-30 |
2003-02-20 |
Okkels Jens Sigurd |
Peptide extended glycosylated polypeptides
|
US7118737B2
(en)
|
2000-09-08 |
2006-10-10 |
Amylin Pharmaceuticals, Inc. |
Polymer-modified synthetic proteins
|
ATE537845T1
(de)
|
2000-10-31 |
2012-01-15 |
Pr Pharmaceuticals Inc |
Verfahren zur herstellung von formulierungen zur verbesserten abgabe von bioaktiven molekülen
|
JP4344136B2
(ja)
|
2000-11-10 |
2009-10-14 |
エフ・ホフマン−ラ・ロシュ・リミテッド |
アポリポタンパク質類似体
|
CA2430934C
(en)
|
2000-12-01 |
2011-06-21 |
Takeda Chemical Industries, Ltd. |
A method of producing sustained-release preparations of a bioactive substance using high-pressure gas
|
JP2004528014A
(ja)
|
2000-12-07 |
2004-09-16 |
イーライ・リリー・アンド・カンパニー |
Glp−1融合タンパク質
|
KR101229995B1
(ko)
|
2000-12-11 |
2013-02-06 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
DE60117919T2
(de)
|
2000-12-11 |
2006-12-14 |
Cheil Jedang Corp. |
Fusionsprotein mit verbesserter in vivo erythropoietinwirkung
|
US8637077B2
(en)
|
2000-12-28 |
2014-01-28 |
Takeda Pharmaceutical Company Limited |
Sustained-release preparation
|
DK1360202T3
(da)
|
2001-02-16 |
2008-09-22 |
Conjuchem Biotechnologies Inc |
Langvarigt glucagon-lignende peptid 2 (GLP-2) til behandling af gastrointestinale sygdomme og lidelser
|
US6987172B2
(en)
|
2001-03-05 |
2006-01-17 |
Washington University In St. Louis |
Multifunctional single chain glycoprotein hormones comprising three or more β subunits
|
US6887462B2
(en)
|
2001-04-09 |
2005-05-03 |
Chiron Corporation |
HSA-free formulations of interferon-beta
|
WO2002085311A2
(en)
|
2001-04-25 |
2002-10-31 |
Acevedo Hernan F |
Hcg formulation
|
US6824769B2
(en)
|
2001-08-28 |
2004-11-30 |
Vertex Pharmaceuticals Incorporated |
Optimal compositions and methods thereof for treating HCV infections
|
GB0121709D0
(en)
|
2001-09-07 |
2001-10-31 |
Imp College Innovations Ltd |
Food inhibition agent
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
US7179617B2
(en)
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
BR0213402A
(pt)
|
2001-10-29 |
2004-10-13 |
Crucell Holland Bv |
Métodos para identificar uma célula de mamìfero capaz de produzir uma molécula proteinácea, para selecionar uma célula de mamìfero capaz de produzir uma molécula proteinácea, para se obter uma célula de mamìfero a partir de uma população heterogênea de células, e para produzir uma molécula proteinácea, composição farmaceuticamente aceitável, eritropoietina recombinantemente produzida, usos de uma célula de mamìfero, da eritropoietina recombinantemente produzida, e de uma composição de moléculas semelhantes à eritropoietina, preparação farmacêutica, método para o tratamento preventivo e/ou terapêutico de um distúrbio, composição de moléculas semelhates à eritropoietina, métodos para produzir, em uma célula de mamìfero, moléculas proteináceas, para produzir uma fração enriquecida em uma molécula proteinácea, e para fracionar uma mistura que contém moléculas proteináceas, fração, e, usos de uma fração ou composição, e de eritropoietina recombinantemente produzìvel em uma célula de mamìfero
|
KR100511749B1
(ko)
|
2001-11-06 |
2005-09-02 |
선바이오(주) |
변형된 인터페론-베타, 및 이의 화학적으로 변형된 배합체
|
KR100467750B1
(ko)
|
2001-11-29 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
KR100467751B1
(ko)
|
2001-12-03 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
CA2471363C
(en)
|
2001-12-21 |
2014-02-11 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US7081446B2
(en)
|
2002-01-31 |
2006-07-25 |
The Trustees Of Columbia University In The City Of New York |
Long-acting follicle stimulating hormone analogues and uses thereof
|
US7173113B2
(en)
|
2002-01-31 |
2007-02-06 |
The Trustees Of Columbia University In The City Of New York |
Long-acting hormone and growth factor compositions and uses thereof
|
GB0206048D0
(en)
|
2002-03-14 |
2002-04-24 |
Croda Int Plc |
Use
|
US20050256035A1
(en)
|
2002-05-13 |
2005-11-17 |
Irving Boime |
Ctp-extended erythropoietin
|
US20070298041A1
(en)
|
2002-06-28 |
2007-12-27 |
Tomlinson Ian M |
Ligands That Enhance Endogenous Compounds
|
CN101664545A
(zh)
|
2002-07-17 |
2010-03-10 |
比奥根艾迪克Ma公司 |
使用干扰素-β治疗肾衰竭
|
US7459435B2
(en)
|
2002-08-29 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
US8129330B2
(en)
|
2002-09-30 |
2012-03-06 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
US7459436B2
(en)
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
BR0317888A
(pt)
|
2002-12-31 |
2005-12-06 |
Altus Pharmaceuticals Inc |
Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
|
EP1595549A4
(en)
|
2003-02-19 |
2010-09-22 |
Takeda Pharmaceutical |
DISPERSING AGENT FOR SUSTAINED RELEASE PREPARATIONS
|
WO2004089280A2
(en)
|
2003-04-08 |
2004-10-21 |
Yeda Research And Development Co. Ltd. |
Reversible pegylated drugs
|
EP1615945B1
(en)
|
2003-04-09 |
2011-09-28 |
BioGeneriX AG |
Glycopegylation methods and proteins/peptides produced by the methods
|
NZ544728A
(en)
|
2003-06-19 |
2009-04-30 |
Bayer Healthcare Llc |
Factor VII or VIIa Gla domain variants
|
CN1245510C
(zh)
|
2003-09-25 |
2006-03-15 |
复旦大学 |
长效重组组织因子途径抑制物及其制备方法
|
WO2005035761A1
(en)
|
2003-10-16 |
2005-04-21 |
Compugen Ltd. |
Splice variants of preproglucagon, glucagon-like peptide-1 and oxyntomodulin
|
CN1243022C
(zh)
|
2003-10-17 |
2006-02-22 |
华东师范大学 |
生物修饰重组人生长激素复合物及其制备方法
|
WO2005047319A2
(en)
|
2003-11-12 |
2005-05-26 |
The University Of Georgia Research Foundation, Inc. |
Dna sequence and expressed recombinant glycoproteins related to feline thyrotropin
|
EP1696947B1
(en)
|
2003-12-19 |
2014-02-26 |
F.Hoffmann-La Roche Ag |
Use of erythropoietin in the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases
|
ATE489105T1
(de)
|
2004-03-19 |
2010-12-15 |
Baxter Int |
Faktor ixa zur behandlung von blutungsstörungen
|
WO2006014579A2
(en)
|
2004-07-08 |
2006-02-09 |
The Regents Of California |
Enhancing class i antigen presentation with synthetic sequences
|
BRPI0514396A2
(pt)
|
2004-08-17 |
2009-05-12 |
Csl Behring Gmbh |
polipeptìdeos dependentes de vitamina k modificada
|
CA2585507A1
(en)
|
2004-09-27 |
2006-04-06 |
Cornell Research Foundation, Inc. |
Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin b-subunit and uses thereof
|
CN101724071A
(zh)
|
2004-10-08 |
2010-06-09 |
杜门蒂斯有限公司 |
抗肿瘤坏死因子受体1的单域抗体及其使用方法
|
GB0521621D0
(en)
|
2005-10-24 |
2005-11-30 |
Domantis Ltd |
Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases
|
EP1728798A1
(en)
|
2005-06-01 |
2006-12-06 |
ZLB Behring GmbH |
Coagulation factor X polypeptides with modified activation properties
|
PT1891105E
(pt)
|
2005-06-13 |
2012-06-27 |
Imp Innovations Ltd |
Análogos de oxintomodulina e seus efeitos sobre o comportamento da alimentação
|
US8759290B2
(en)
|
2005-10-18 |
2014-06-24 |
Biocon Limited |
Oral glucagon-like peptide conjugates for metabolic diseases
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8304386B2
(en)
|
2006-02-03 |
2012-11-06 |
Prolor Biotech, Inc. |
Long-acting growth hormone and methods of producing same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US7553940B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting EPO polypeptides and derivatives thereof and methods thereof
|
US9458444B2
(en)
*
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US9249407B2
(en)
*
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
EP1991574B1
(en)
|
2006-02-22 |
2016-10-12 |
Merck Sharp & Dohme Corp. |
Oxyntomodulin derivatives
|
TW200806317A
(en)
|
2006-03-20 |
2008-02-01 |
Wyeth Corp |
Methods for reducing protein aggregation
|
EP2423305A1
(en)
|
2006-06-19 |
2012-02-29 |
Catalyst Biosciences, Inc. |
Modified coagulation factor IX polypeptides and use thereof for treatment
|
CN105838699A
(zh)
*
|
2006-12-15 |
2016-08-10 |
巴克斯艾尔塔公司 |
具有延长的体内半衰期的因子VIIa-聚唾液酸结合物
|
DE102007006189B4
(de)
|
2007-02-07 |
2009-07-30 |
Isotopen Technologien München AG |
Vorrichtung zum Befüllen eines medizinischen Instruments mit einer radioaktiven Substanz und Verfahren
|
AT505262A1
(de)
|
2007-06-12 |
2008-12-15 |
Apeiron Biolog Forschungs Und |
Rekombinantes ace2 polypeptid
|
CN101952421A
(zh)
|
2007-12-05 |
2011-01-19 |
诺维信公司 |
具有内切葡聚糖酶活性的多肽和编码所述多肽的多核苷酸
|
BRPI0917000A2
(pt)
|
2008-08-06 |
2016-02-16 |
Novo Nordisk Healthcare Ag |
proteínas conjugadas com eficácia in vivo prolongada
|
EP2341942A1
(en)
|
2008-09-19 |
2011-07-13 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|
US20110171164A1
(en)
|
2008-09-19 |
2011-07-14 |
Nektar Therapeutics |
Polymer conjugates of glp-2-like peptides
|
AU2010217045B2
(en)
|
2009-02-27 |
2013-02-07 |
Guhring Ohg |
Modular automated tool dispenser
|
CN101824087A
(zh)
|
2009-03-05 |
2010-09-08 |
连云港恒邦医药科技有限公司 |
胰高血糖素样肽-2类似物及其制备方法和用途
|
US8828953B2
(en)
|
2009-04-20 |
2014-09-09 |
NaZura BioHealth, Inc. |
Chemosensory receptor ligand-based therapies
|
FR2947181B1
(fr)
|
2009-06-26 |
2012-05-04 |
Lfb Biotechnologies |
Composition de facteur vii
|
DE102009031992A1
(de)
|
2009-07-06 |
2011-01-13 |
Paul Hartmann Ag |
Vorrichtung zur Unterdrucktherapie von Wunden
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
EP2314616A1
(en)
|
2009-10-23 |
2011-04-27 |
Ferring B.V. |
Peptidic GLP-2 agonists
|
JO2976B1
(en)
|
2009-12-22 |
2016-03-15 |
ايلي ليلي اند كومباني |
Axentomodulin polypeptide
|
AR079344A1
(es)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
Analogo peptidico de oxintomodulina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar diabetes no insulinodependiente y/u obesidad
|
KR101382593B1
(ko)
|
2010-07-21 |
2014-04-10 |
한미사이언스 주식회사 |
신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
JP6182134B2
(ja)
|
2011-06-02 |
2017-08-16 |
オプコ バイオロジクス リミテッド |
長時間作用型glp−1/グルカゴン受容体アゴニスト
|
EP2721062B1
(en)
|
2011-06-17 |
2018-11-14 |
Hanmi Science Co., Ltd. |
A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
|
US9573987B2
(en)
|
2011-12-20 |
2017-02-21 |
Indiana University Research And Technology Corporation |
CTP-based insulin analogs for treatment of diabetes
|
KR101895047B1
(ko)
|
2011-12-30 |
2018-09-06 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체
|
KR102310704B1
(ko)
*
|
2012-02-14 |
2021-10-08 |
옵코 바이오로직스 리미티드 |
장기 작용 응고 인자들 및 이를 생산하는 방법들
|
PE20142405A1
(es)
|
2012-04-19 |
2015-01-25 |
Opko Biolog Ltd |
Variantes de oxintomodulina de accion prolongada y metodos de produccion de las mismas
|
CN109096387B
(zh)
|
2012-06-04 |
2021-11-30 |
奥普科生物制品有限公司 |
聚乙二醇化的oxm变体
|
US20150307865A1
(en)
|
2012-10-15 |
2015-10-29 |
Novo Nordisk Health Care Ag |
Coagulation factor vii polypeptides
|
SG10202010383YA
(en)
|
2012-11-20 |
2020-11-27 |
Opko Biologics Ltd |
Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
RU2021103436A
(ru)
*
|
2014-12-10 |
2021-02-25 |
Опко Байолоджикс Лтд. |
Способы производства ctp-модифицированных полипептидов гормона роста длительного действия
|
CN108289851B
(zh)
*
|
2015-06-19 |
2021-06-01 |
Opko生物科学有限公司 |
长效凝固因子及其产生方法
|
KR20240006077A
(ko)
|
2016-07-11 |
2024-01-12 |
옵코 바이오로직스 리미티드 |
지속성 응고 인자 vii 및 그 제조 방법
|